A Phase 3 Study to Evaluate the Safety and Efficacy of Tc-MIP-1404 SPECT/CT Imaging to Detect Clinically Significant Prostate Cancer in Men with Biospy Proven Low-Grade Prostate Cancer who are Candidates for Active Surveillance
|Effective start/end date||3/31/16 → 3/30/18|
- PROGENICS PHARMACEUTICALS, INC.
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.